University of Cincinnati, Ohio; Higher Education, Public Coll/Univ - Unlimited Student Fees Apr 02

  • ID: 1781264
  • April 2002
  • Region: Ohio
  • Standard & Poors
1 of 3


  • University of Cincinnati
  • MORE

The 'SP-1+' rating on the University of Cincinnati (UC), Ohio's general-receipts BANs, series 2002E, reflects the university's: Strong market-access record, Strong, 'AA' long-term rating, and Parity lien on pledged general receipts. In addition, the 'AA' rating on the 2002D general-receipts bonds and outstanding parity bonds reflects the university's long-term credit quality. Within the general-receipts program, the university's BANs are on parity with outstanding bonds. After the issuance, there will be outstanding $385.2 million in bonds and $55.6 million in notes. The university has a long and successful history of short-term borrowing for capital projects, with either repayment or conversion to permanent financing once the projects are complete. Post-issuance short-term debt is a manageable $55.6 million, around 12.6% of general-receipts debt...

Companies mentioned in this report are:
- University of Cincinnati

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- University of Cincinnati

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.